

Search

EN

Back

Eli Lilly Surpasses $1 Trillion Valuation Driven by Strong Sales of Mounjaro and Zepbound

Back

Stock NewsThemesEli Lilly Surpasses $1 Trillion Valuation Driven by Strong Sales of Mounjaro and Zepbound

Eli Lilly Surpasses $1 Trillion Valuation Driven by Strong Sales of Mounjaro and Zepbound

Edgen Stock·Nov 22 2025, 02:37

Share to

Share to

Copy link

source:

[1] Eli Lilly hits $1 trillion market value, first for health care ...[2] Eli Lilly Stock (LLY) Achieves $1 Trillion Market Cap [3] Eli Lilly Becomes First Pharma To Join $1 Trillion Club ...

Recommend

Celanese Q4 Earnings Plunge 54%, Missing EstimatesFeb 17 2026, 23:34 RB Global Beats Q4 Estimates With $1.11 EPSFeb 17 2026, 23:33 Mercury General Crushes Q4 Forecasts With $3.66 EPSFeb 17 2026, 23:32

Hot News

Similarweb Swings to Profit, Beating Q4 EstimatesFeb 17 2026, 23:58

Hormel Sells Turkey Business, Reaffirms 2026 GuidanceFeb 17 2026, 23:57

Axcelis Q4 Profit Crushes Estimates by 33%Feb 17 2026, 23:35

Halozyme Reports Unexpected Q4 Loss of $0.24 Per ShareFeb 17 2026, 23:35

Features

AI Copilot for Stock & Crypto

Price Prediction

Fundraise Tracker

Crypto Comparison

Resources

Market

Terms of Use Privacy Policy Sitemap

© 2026 Finture Development Limited. All rights reserved